NCT04054518 Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT04045496 A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04009265 Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma Status RECRUITING Phase PHASE3
NCT03985046 Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC Status COMPLETED Phase PHASE2
NCT03964753 Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT03958890 A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC) Status UNKNOWN Phase PHASE3
NCT03946969 Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT03940976 Afatinib in Previously Treated ESCC With EGFR Overexpression or EGFR Amplification (ESCC-A01) Status UNKNOWN Phase PHASE2
NCT03940001 A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer Status UNKNOWN Phase EARLY_PHASE1
NCT03927495 KN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03925870 KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03922230 Exploration and Verification of DNA Methylolation in Early Screening of Esophageal Cancer Status UNKNOWN Phase N/A
NCT03913182 Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT03888092 Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification Status COMPLETED Phase PHASE1/PHASE2
NCT03857763 A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03833466 Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo) Status UNKNOWN Phase PHASE2
NCT03817658 A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC Status UNKNOWN Phase PHASE2
NCT03817567 Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE1/PHASE2